These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 10749663

  • 1. Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
    Tacken PJ, Beer FD, Vark LC, Havekes LM, Hofker MH, Willems Van Dijk K.
    Biochem J; 2000 Apr 15; 347(Pt 2):357-61. PubMed ID: 10749663
    [Abstract] [Full Text] [Related]

  • 2. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
    Medh JD, Fry GL, Bowen SL, Ruben S, Wong H, Chappell DA.
    J Lipid Res; 2000 Nov 15; 41(11):1858-71. PubMed ID: 11060356
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC, van Dijk KW, Dahlmans VE, Van der Boom H, Kobayashi K, Oka K, Siest G, Chan L, Hofker MH, Havekes LM.
    Biochem J; 1999 Mar 01; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [Abstract] [Full Text] [Related]

  • 6. Hyperlipidemia of ApoE2(Arg(158)-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression.
    van Dijk KW, van Vlijmen BJ, de Winther MP, van 't Hof B, van der Zee A, van der Boom H, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1999 Dec 01; 19(12):2945-51. PubMed ID: 10591674
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity.
    de Beer F, Hendriks WL, van Vark LC, Kamerling SW, van Dijk KW, Hofker MH, Smelt AH, Havekes LM.
    Arterioscler Thromb Vasc Biol; 1999 Mar 01; 19(3):633-7. PubMed ID: 10073967
    [Abstract] [Full Text] [Related]

  • 10. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
    de Man FH, de Beer F, van de Laarse A, Smelt AH, Leuven JA, Havekes LM.
    Atherosclerosis; 1998 Feb 01; 136(2):255-62. PubMed ID: 9543096
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
    Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T.
    J Biol Chem; 1995 Jun 30; 270(26):15747-54. PubMed ID: 7797576
    [Abstract] [Full Text] [Related]

  • 13. Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor.
    Knouff C, Briand O, Lestavel S, Clavey V, Altenburg M, Maeda N.
    Biochim Biophys Acta; 2004 Aug 30; 1684(1-3):8-17. PubMed ID: 15450205
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors.
    Mann WA, Meyer N, Berg D, Greten H, Beisiegel U.
    Atherosclerosis; 1999 Jul 30; 145(1):61-9. PubMed ID: 10428296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression of human lipoprotein lipase enhances uptake of lipoproteins containing apolipoprotein B-100 in transfected cells.
    Kawamura M, Shimano H, Gotoda T, Harada K, Shimada M, Ohsuga J, Inaba T, Watanabe Y, Yamamoto K, Kozaki K.
    Arterioscler Thromb; 1994 Feb 30; 14(2):235-42. PubMed ID: 8305414
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Conformation of apolipoprotein E both in free and in lipid-bound form may determine the avidity of triglyceride-rich lipoproteins to the LDL receptor: structural and kinetic study.
    Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biochim Biophys Acta; 2000 Feb 24; 1484(1):14-28. PubMed ID: 10685027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.